About Retinor Pharmaceutical Private Limited
Data last updated:
Retinor Pharmaceutical Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24303TG2018PTC124556. Its GSTIN is 06AAICR9573L1ZM (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajay Mahana and Kamaljeet Kaur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 205 Plot No.1 – 98/5A&5B Jyothi Residency Vittal Rao Nagar, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.9 Cr, a growth of 67% compared to the previous year. For the same year it recorded a net profit of ₹16.58 Lakh (net margin 2.8%) and EBITDA of ₹17.09 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 149% over three years and 13% over five years.
For more details, the company can be reached via its website retinor.in.
Company details
Contact details
Retinor Pharmaceutical Private Limited's registered office is in Hyderabad, Telangana. Its website is retinor.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No. 205 Plot No.1 – 98/5A&5B Jyothi Residency Vittal Rao Nagar, Hyderabad, Telangana, India – 500081
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Retinor Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Retinor Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Retinor Pharmaceutical Private Limited, buy the company report.
Financials of Retinor Pharmaceutical Private Limited
FY 2025 filings availableRetinor Pharmaceutical Private Limited reported revenue of ₹5.9 Cr (up 67% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 67% growth in the latest year. EBITDA rose 138% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.09 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.58 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Retinor Pharmaceutical Private Limited, buy the company report.
Board of directors of Retinor Pharmaceutical Private Limited
Retinor Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Mahana | Director | 17 May 2018 | 8 Years 5 Months | Current |
| Kamaljeet Kaur | Director | 17 May 2018 | 8 Years 5 Months | Current |
Auditor
Retinor Pharmaceutical Private Limited is audited by RAJIV GOEL & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJIV GOEL & ASSOCIATES | FY 2022 | 011106N |
Shareholding
The shareholding of Retinor Pharmaceutical Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Retinor Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Retinor Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Retinor Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Retinor Pharmaceutical has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAICR9573L1ZM | Haryana | Active | 26 Jul 2018 |
To see the full GST registrations and return filing status of Retinor Pharmaceutical Private Limited, buy the company report.
Recent activity
Retinor Pharmaceutical Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Bhagya Lakshmi Patti ceased to be Director on 03 Aug 2021.
Frequently asked questions
Retinor Pharmaceutical is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 May 2018 (8+ years old) and is registered under CIN U24303TG2018PTC124556.
Retinor Pharmaceutical has 2 current directors:
- Ajay Mahana - Director
- Kamaljeet Kaur - Director
The latest financial statements of Retinor Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Retinor Pharmaceutical is 06AAICR9573L1ZM, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Retinor Pharmaceutical is U24303TG2018PTC124556. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Retinor Pharmaceutical was incorporated on 17 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Bhagya Lakshmi Patti ceased to be Director on 03 Aug 2021. Aditya Seth ceased to be Director on 06 May 2019. Ajay Mahana was appointed as Director on 17 May 2018. Retinor Pharmaceutical has 4 board changes on record in total.
Retinor Pharmaceutical can be reached through the website retinor.in. Its registered office is in Hyderabad, Telangana, India.
The registered office of Retinor Pharmaceutical is at Flat No. 205 Plot No.1 – 985A&5B Jyothi Residency Vittal Rao Nagar, Hyderabad, Telangana, India – 500081.
Retinor Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
